15 янв. 2024 г. · Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with systemic sclerosis (SSc).

20 авг. 2020 г. · Interstitial lung disease associated with systemic sclerosis (SSc-ILD) is one of the important pulmonary manifestations of systemic sclerosis. ...

Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent advances in the treatment is, at present, the major cause ... The relevance of interstitial... · Pathogenesis

9 дек. 2019 г. · Interstitial lung disease (ILD) is identified in the majority of patients with SSc and is the leading cause of SSc-related mortality.

3 нояб. 2023 г. · SSc is a rare, highly heterogeneous, systemic autoimmune disease with high mortality. ILD is one of the main causes of morbidity and mortality ...

27 февр. 2020 г. · Systemic sclerosis-associated interstitial lung disease most commonly presents with dyspnoea, cough, and a non-specific interstitial pneumonia ...

Interstitial lung disease (ILD) is a leading cause of both morbidity and mortality in systemic sclerosis (SSc). Radiographic lung abnormalities on ...

18 янв. 2019 г. · ILD is a common manifestation of SSc that is associated with early mortality. After diagnosis, all patients with SSc can benefit from an HRCT ...

Scleroderma-associated interstitial lung disease, or “SSc-ILD”, is a chronic lung disease in which scar tissue (“fibrosis”) and/or inflammation builds up in the ...

10 окт. 2024 г. · Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) that is often progressive and has a poor prognosis [1-7] ...